2-177663872-C-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_016953.4(PDE11A):​c.2640G>T​(p.Leu880Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000826 in 1,573,058 control chromosomes in the GnomAD database, including 22 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.00042 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00087 ( 21 hom. )

Consequence

PDE11A
NM_016953.4 missense

Scores

3
11
4

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.400

Publications

1 publications found
Variant links:
Genes affected
PDE11A (HGNC:8773): (phosphodiesterase 11A) The 3',5'-cyclic nucleotides cAMP and cGMP function as second messengers in a wide variety of signal transduction pathways. 3',5'-cyclic nucleotide phosphodiesterases (PDEs) catalyze the hydrolysis of cAMP and cGMP to the corresponding 5'-monophosphates and provide a mechanism to downregulate cAMP and cGMP signaling. This gene encodes a member of the PDE protein superfamily. Mutations in this gene are a cause of Cushing disease and adrenocortical hyperplasia. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
PDE11A-AS1 (HGNC:40433): (PDE11A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.018030494).
BP6
Variant 2-177663872-C-A is Benign according to our data. Variant chr2-177663872-C-A is described in ClinVar as [Benign]. Clinvar id is 741896.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00042 (64/152294) while in subpopulation SAS AF = 0.0126 (61/4826). AF 95% confidence interval is 0.0101. There are 1 homozygotes in GnomAd4. There are 49 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 64 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PDE11ANM_016953.4 linkc.2640G>T p.Leu880Phe missense_variant Exon 19 of 20 ENST00000286063.11 NP_058649.3 Q9HCR9-1
PDE11ANM_001077197.2 linkc.1890G>T p.Leu630Phe missense_variant Exon 20 of 21 NP_001070665.1 Q9HCR9-2
PDE11ANM_001077358.2 linkc.1566G>T p.Leu522Phe missense_variant Exon 18 of 19 NP_001070826.1 Q9HCR9-3
PDE11ANM_001077196.2 linkc.1308G>T p.Leu436Phe missense_variant Exon 16 of 17 NP_001070664.1 Q9HCR9-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PDE11AENST00000286063.11 linkc.2640G>T p.Leu880Phe missense_variant Exon 19 of 20 1 NM_016953.4 ENSP00000286063.5 Q9HCR9-1

Frequencies

GnomAD3 genomes
AF:
0.000434
AC:
66
AN:
152176
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.0130
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00176
AC:
442
AN:
251052
AF XY:
0.00232
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000653
GnomAD4 exome
AF:
0.000869
AC:
1235
AN:
1420764
Hom.:
21
Cov.:
25
AF XY:
0.00128
AC XY:
907
AN XY:
709638
show subpopulations
African (AFR)
AF:
0.0000306
AC:
1
AN:
32682
American (AMR)
AF:
0.00
AC:
0
AN:
44664
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25888
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39518
South Asian (SAS)
AF:
0.0137
AC:
1168
AN:
85386
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53390
Middle Eastern (MID)
AF:
0.00105
AC:
6
AN:
5694
European-Non Finnish (NFE)
AF:
0.00000745
AC:
8
AN:
1074468
Other (OTH)
AF:
0.000880
AC:
52
AN:
59074
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
67
134
201
268
335
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000420
AC:
64
AN:
152294
Hom.:
1
Cov.:
32
AF XY:
0.000658
AC XY:
49
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41568
American (AMR)
AF:
0.00
AC:
0
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5184
South Asian (SAS)
AF:
0.0126
AC:
61
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68028
Other (OTH)
AF:
0.00
AC:
0
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000434
Hom.:
0
Bravo
AF:
0.0000793
ExAC
AF:
0.00196
AC:
238
Asia WGS
AF:
0.00462
AC:
16
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.96
BayesDel_addAF
Benign
0.0050
T
BayesDel_noAF
Pathogenic
0.25
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.51
D;.;.;.
Eigen
Uncertain
0.41
Eigen_PC
Uncertain
0.48
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Pathogenic
0.98
D;D;D;D
MetaRNN
Benign
0.018
T;T;T;T
MetaSVM
Benign
-0.36
T
MutationAssessor
Uncertain
2.4
M;.;.;.
PhyloP100
0.40
PrimateAI
Uncertain
0.57
T
PROVEAN
Uncertain
-2.9
D;D;D;D
REVEL
Uncertain
0.64
Sift
Uncertain
0.0030
D;D;D;D
Sift4G
Uncertain
0.0060
D;D;D;D
Polyphen
1.0
D;.;.;D
Vest4
0.86
MutPred
0.72
Gain of catalytic residue at Q882 (P = 0.1494);.;.;.;
MVP
0.77
MPC
0.66
ClinPred
0.12
T
GERP RS
6.1
Varity_R
0.77
gMVP
0.44
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs374942202; hg19: chr2-178528600; API